Impaired fecal elastase excretion in uremic pancreopathy

Dig Dis Sci. 2000 Nov;45(11):2265-9. doi: 10.1023/a:1026487807555.

Abstract

To evaluate pancreatic exocrine function in uremia, 25 patients undergoing regular hemodialysis without clinical evidence of pancreatic disease and 25 healthy control subjects were studied by fecal elastase 1 and chymotrypsin. Abdominal ultrasonography and measurement of serum lipase, calcium, phosphate, and parathormone were also carried out. Fecal elastase was significantly lower (P < 0.001) in patients than in controls. Abnormally low values were found in 12/25 patients of whom six had values <100 microg/g. Fecal chymotrypsin was significantly lower (P < 0.05) in patients than in controls, with lower than normal values found in 10/25 patients. Fecal elastase was not related to the serum calcium, phosphate, or parathormone levels or to the period of dialysis. In patients serum lipase was normal or slightly elevated (<300 units/liter), and there was no evidence of pancreatic disease at ultrasound examination. The results lend further support to the existence of pancreatic function impairment in a significant number of patients with renal failure despite the absence of clinical and morphological evidence of pancreatic disease.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Chymotrypsin / analysis
  • Feces / chemistry*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Elastase / analysis*
  • Pancreatic Function Tests
  • Pancreatitis / diagnosis*
  • Reference Values
  • Renal Dialysis*
  • Uremia / complications*
  • Uremia / diagnosis

Substances

  • Chymotrypsin
  • Pancreatic Elastase